129 related articles for article (PubMed ID: 27490827)
1. Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy.
Cameron KO; Kung DW; Kalgutkar AS; Kurumbail RG; Miller R; Salatto CT; Ward J; Withka JM; Bhattacharya SK; Boehm M; Borzilleri KA; Brown JA; Calabrese M; Caspers NL; Cokorinos E; Conn EL; Dowling MS; Edmonds DJ; Eng H; Fernando DP; Frisbie R; Hepworth D; Landro J; Mao Y; Rajamohan F; Reyes AR; Rose CR; Ryder T; Shavnya A; Smith AC; Tu M; Wolford AC; Xiao J
J Med Chem; 2016 Sep; 59(17):8068-81. PubMed ID: 27490827
[TBL] [Abstract][Full Text] [Related]
2. Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1 H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK).
Ryder TF; Calabrese MF; Walker GS; Cameron KO; Reyes AR; Borzilleri KA; Delmore J; Miller R; Kurumbail RG; Ward J; Kung DW; Brown JA; Edmonds DJ; Eng H; Wolford AC; Kalgutkar AS
J Med Chem; 2018 Aug; 61(16):7273-7288. PubMed ID: 30036059
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5'-Adenosine Monophosphate-Activated Protein Kinase (AMPK).
Edmonds DJ; Kung DW; Kalgutkar AS; Filipski KJ; Ebner DC; Cabral S; Smith AC; Aspnes GE; Bhattacharya SK; Borzilleri KA; Brown JA; Calabrese MF; Caspers NL; Cokorinos EC; Conn EL; Dowling MS; Eng H; Feng B; Fernando DP; Genung NE; Herr M; Kurumbail RG; Lavergne SY; Lee EC; Li Q; Mathialagan S; Miller RA; Panteleev J; Polivkova J; Rajamohan F; Reyes AR; Salatto CT; Shavnya A; Thuma BA; Tu M; Ward J; Withka JM; Xiao J; Cameron KO
J Med Chem; 2018 Mar; 61(6):2372-2383. PubMed ID: 29466005
[TBL] [Abstract][Full Text] [Related]
4. Selective Activation of AMPK
Salatto CT; Miller RA; Cameron KO; Cokorinos E; Reyes A; Ward J; Calabrese MF; Kurumbail RG; Rajamohan F; Kalgutkar AS; Tess DA; Shavnya A; Genung NE; Edmonds DJ; Jatkar A; Maciejewski BS; Amaro M; Gandhok H; Monetti M; Cialdea K; Bollinger E; Kreeger JM; Coskran TM; Opsahl AC; Boucher GG; Birnbaum MJ; DaSilva-Jardine P; Rolph T
J Pharmacol Exp Ther; 2017 May; 361(2):303-311. PubMed ID: 28289077
[TBL] [Abstract][Full Text] [Related]
5. Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators.
Dokla EM; Fang CS; Lai PT; Kulp SK; Serya RA; Ismail NS; Abouzid KA; Chen CS
ChemMedChem; 2015 Nov; 10(11):1915-23. PubMed ID: 26350292
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators.
Cameron KO; Kurumbail RG
Bioorg Med Chem Lett; 2016 Nov; 26(21):5139-5148. PubMed ID: 27727125
[TBL] [Abstract][Full Text] [Related]
7. Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.
Cokorinos EC; Delmore J; Reyes AR; Albuquerque B; Kjøbsted R; Jørgensen NO; Tran JL; Jatkar A; Cialdea K; Esquejo RM; Meissen J; Calabrese MF; Cordes J; Moccia R; Tess D; Salatto CT; Coskran TM; Opsahl AC; Flynn D; Blatnik M; Li W; Kindt E; Foretz M; Viollet B; Ward J; Kurumbail RG; Kalgutkar AS; Wojtaszewski JFP; Cameron KO; Miller RA
Cell Metab; 2017 May; 25(5):1147-1159.e10. PubMed ID: 28467931
[TBL] [Abstract][Full Text] [Related]
8. (WO2011057959) indole and indazole derivatives as glycogen synthase activators: a patent evaluation.
Skaltsounis AL; Gaboriaud-Kolar N
Expert Opin Ther Pat; 2011 Dec; 21(12):1925-9. PubMed ID: 21988345
[TBL] [Abstract][Full Text] [Related]
9. In silico Analysis of AMP-activated Protein Kinase and Ligand-based Virtual Screening for Identification of Novel AMPK Activators.
Ghaffar A; Batool S; Mushtaq G; Kamal MA
Curr Comput Aided Drug Des; 2017; 13(3):222-233. PubMed ID: 28294049
[TBL] [Abstract][Full Text] [Related]
10. Development of novel adenosine monophosphate-activated protein kinase activators.
Guh JH; Chang WL; Yang J; Lee SL; Wei S; Wang D; Kulp SK; Chen CS
J Med Chem; 2010 Mar; 53(6):2552-61. PubMed ID: 20170185
[TBL] [Abstract][Full Text] [Related]
11. Discovery, synthesis, and structure-activity relationships of 20(S)-protopanaxadiol (PPD) derivatives as a novel class of AMPKα2β1γ1 activators.
Liu J; Chen D; Liu P; He M; Li J; Li J; Hu L
Eur J Med Chem; 2014 May; 79():340-9. PubMed ID: 24747289
[TBL] [Abstract][Full Text] [Related]
12. AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants.
Shrikanth CB; Nandini CD
Phytomedicine; 2020 Jul; 73():152808. PubMed ID: 30935723
[TBL] [Abstract][Full Text] [Related]
13. Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach.
Huang T; Sun J; Zhou S; Gao J; Liu Y
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665353
[TBL] [Abstract][Full Text] [Related]
14. Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer.
Kuramoto K; Yamada H; Shin T; Sawada Y; Azami H; Yamada T; Nagashima T; Ohnuki K
Bioorg Med Chem; 2020 Mar; 28(5):115307. PubMed ID: 32007387
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
Oh S; Kim SJ; Hwang JH; Lee HY; Ryu MJ; Park J; Kim SJ; Jo YS; Kim YK; Lee CH; Kweon KR; Shong M; Park SB
J Med Chem; 2010 Oct; 53(20):7405-13. PubMed ID: 20873794
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-containing pyrazolo[3,4-b]pyridinones as a new series of AMPKɑ1β1γ1 activators.
Xiao Z; Peng Y; Zheng B; Chang Q; Guo Y; Chen Z; Li Q; Hu G
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000458. PubMed ID: 33683726
[TBL] [Abstract][Full Text] [Related]
17. Discovery of natural adenosine monophosphate‑activated protein kinase activators through virtual screening and activity verification studies.
Hao J; Yang Z; Li J; Han L; Zhang Y; Wang T
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495803
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators.
Wang J; Liu J; Xie Z; Li J; Li J; Hu L
Bioorg Med Chem Lett; 2020 Jan; 30(2):126790. PubMed ID: 31744674
[TBL] [Abstract][Full Text] [Related]
19. Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
Gong L; Han X; Silva T; Tan YC; Goyal B; Tivitmahaisoon P; Trejo A; Palmer W; Hogg H; Jahagir A; Alam M; Wagner P; Stein K; Filonova L; Loe B; Makra F; Rotstein D; Rapatova L; Dunn J; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Hermann J; Kuglstatter A; Goldstein D
Bioorg Med Chem Lett; 2013 Jun; 23(12):3565-9. PubMed ID: 23664880
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates.
Zhang HC; Derian CK; Andrade-Gordon P; Hoekstra WJ; McComsey DF; White KB; Poulter BL; Addo MF; Cheung WM; Damiano BP; Oksenberg D; Reynolds EE; Pandey A; Scarborough RM; Maryanoff BE
J Med Chem; 2001 Mar; 44(7):1021-4. PubMed ID: 11297447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
